| 1 |
Duan S, Xia Y, Tian X, Cui J, Zhang X, Yang Q, Zhao T, Lin Y, Zhang F, Zhang X, Cen J. A multi-bioresponsive self-assembled nano drug delivery system based on hyaluronic acid and geraniol against liver cancer. Carbohydr Polym 2023;310:120695. [PMID: 36925236 DOI: 10.1016/j.carbpol.2023.120695] [Reference Citation Analysis]
|
| 2 |
Yang MH, Ha IJ, Ahn J, Kim CK, Lee M, Ahn KS. Potential function of loliolide as a novel blocker of epithelial-mesenchymal transition in colorectal and breast cancer cells. Cell Signal 2023;105:110610. [PMID: 36707041 DOI: 10.1016/j.cellsig.2023.110610] [Reference Citation Analysis]
|
| 3 |
Kim NY, Ha IJ, Um JY, Kumar AP, Sethi G, Ahn KS. Loganic acid regulates the transition between epithelial and mesenchymal-like phenotypes by alleviating MnSOD expression in hepatocellular carcinoma cells. Life Sci 2023;317:121458. [PMID: 36731649 DOI: 10.1016/j.lfs.2023.121458] [Reference Citation Analysis]
|
| 4 |
Shi ZD, Pang K, Wu ZX, Dong Y, Hao L, Qin JX, Wang W, Chen ZS, Han CH. Tumor cell plasticity in targeted therapy-induced resistance: mechanisms and new strategies. Signal Transduct Target Ther 2023;8:113. [PMID: 36906600 DOI: 10.1038/s41392-023-01383-x] [Reference Citation Analysis]
|
| 5 |
Ahmad GM, Abu Serie MM, Abdel-Latif MS, Ghoneem T, Ghareeb DA, Yacout GA. Potential anti-proliferative activity of Salix mucronata and Triticum spelta plant extracts on liver and colorectal cancer cell lines. Sci Rep 2023;13:3815. [PMID: 36882428 DOI: 10.1038/s41598-023-30845-z] [Reference Citation Analysis]
|
| 6 |
Hu P, Zong B, Chen Q, Shao R, Chen M, Yang Y, Shao G. Microtubule-associated protein 4 promotes epithelial mesenchymal transition in hepatocellular cancer cells via regulating GSK3β/β-catenin pathway. Heliyon 2023;9:e14309. [PMID: 36938447 DOI: 10.1016/j.heliyon.2023.e14309] [Reference Citation Analysis]
|
| 7 |
Dai Z, Huang Q, Huang X, Zhu C, Zahid KR, Liu T, Li Q, Wu C, Peng M, Xiao X, Raza U, Yu N, Zeng T. KIN17 promotes cell migration and invasion through stimulating the TGF-β/Smad2 pathway in hepatocellular carcinoma. Mol Carcinog 2023;62:369-84. [PMID: 36468848 DOI: 10.1002/mc.23492] [Reference Citation Analysis]
|
| 8 |
El-Daly SM, El-Bana MA, Abd El-Rahman SS, Latif YA, Medhat D. Dynamic expression of H19 and MALAT1 and their correlation with tumor progression biomarkers in a multistage hepatocarcinogenesis model. Cell Biochem Funct 2023. [PMID: 36861261 DOI: 10.1002/cbf.3785] [Reference Citation Analysis]
|
| 9 |
Tuli HS, Bhushan S, Kumar A, Aggarwal P, Sak K, Ramniwas S, Vashishth K, Behl T, Rana R, Haque S, Prieto MA. Autophagy Induction by Scutellaria Flavones in Cancer: Recent Advances. Pharmaceuticals 2023;16:302. [DOI: 10.3390/ph16020302] [Reference Citation Analysis]
|
| 10 |
Weber F, Treeck O, Mester P, Buechler C. Expression and Function of BMP and Activin Membrane-Bound Inhibitor (BAMBI) in Chronic Liver Diseases and Hepatocellular Carcinoma. Int J Mol Sci 2023;24. [PMID: 36834884 DOI: 10.3390/ijms24043473] [Reference Citation Analysis]
|
| 11 |
Hashemi M, Nadafzadeh N, Imani MH, Rajabi R, Ziaolhagh S, Bayanzadeh SD, Norouzi R, Rafiei R, Koohpar ZK, Raei B, Zandieh MA, Salimimoghadam S, Entezari M, Taheriazam A, Alexiou A, Papadakis M, Tan SC. Targeting and regulation of autophagy in hepatocellular carcinoma: revisiting the molecular interactions and mechanisms for new therapy approaches. Cell Commun Signal 2023;21:32. [PMID: 36759819 DOI: 10.1186/s12964-023-01053-z] [Reference Citation Analysis]
|
| 12 |
Muto S, Enta A, Maruya Y, Inomata S, Yamaguchi H, Mine H, Takagi H, Ozaki Y, Watanabe M, Inoue T, Yamaura T, Fukuhara M, Okabe N, Matsumura Y, Hasegawa T, Osugi J, Hoshino M, Higuchi M, Shio Y, Hamada K, Suzuki H. Wnt/β-Catenin Signaling and Resistance to Immune Checkpoint Inhibitors: From Non-Small-Cell Lung Cancer to Other Cancers. Biomedicines 2023;11. [PMID: 36672698 DOI: 10.3390/biomedicines11010190] [Reference Citation Analysis]
|
| 13 |
Jeng KS, Chang CF, Sheen IS, Jeng CJ, Wang CH. Cellular and Molecular Biology of Cancer Stem Cells of Hepatocellular Carcinoma. Int J Mol Sci 2023;24. [PMID: 36674932 DOI: 10.3390/ijms24021417] [Reference Citation Analysis]
|
| 14 |
Paskeh MDA, Ghadyani F, Hashemi M, Abbaspour A, Zabolian A, Javanshir S, Razzazan M, Mirzaei S, Entezari M, Goharrizi MASB, Salimimoghadam S, Aref AR, Kalbasi A, Rajabi R, Rashidi M, Taheriazam A, Sethi G. Biological impact and therapeutic perspective of targeting PI3K/Akt signaling in hepatocellular carcinoma: Promises and Challenges. Pharmacol Res 2023;187:106553. [PMID: 36400343 DOI: 10.1016/j.phrs.2022.106553] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 15 |
Hashemi M, Mirzaei S, Zandieh MA, Rezaei S, Amirabbas Kakavand, Dehghanpour A, Esmaeili N, Ghahremanzade A, Saebfar H, Heidari H, Salimimoghadam S, Taheriazam A, Entezari M, Ahn KS. Long non-coding RNAs (lncRNAs) in hepatocellular carcinoma progression: Biological functions and new therapeutic targets. Prog Biophys Mol Biol 2023;177:207-28. [PMID: 36584761 DOI: 10.1016/j.pbiomolbio.2022.12.004] [Reference Citation Analysis]
|
| 16 |
Jose A, Bavetta MG, Martinelli E, Bronte F, Giunta EF, Manu KA. Hepatocellular Carcinoma: Current Therapeutic Algorithm for Localized and Advanced Disease. J Oncol 2022;2022:3817724. [PMID: 36624801 DOI: 10.1155/2022/3817724] [Reference Citation Analysis]
|
| 17 |
Zhao Z, Su J, Zhao J, Chen J, Cui X, Sun M, Zhang X. Curcumin inhibits invasion and metastasis of human hepatoma cells through Bclaf1-mediated Wnt/β-catenin signalling. Food and Agricultural Immunology 2022;33:664-76. [DOI: 10.1080/09540105.2022.2113864] [Reference Citation Analysis]
|
| 18 |
Sin SQ, Mohan CD, Goh RMW, You M, Nayak SC, Chen L, Sethi G, Rangappa KS, Wang L. Hypoxia signaling in hepatocellular carcinoma: Challenges and therapeutic opportunities. Cancer Metastasis Rev 2022. [DOI: 10.1007/s10555-022-10071-1] [Reference Citation Analysis]
|
| 19 |
Choudhury J, Kanika K, Chaturvedi PK, Gupta S. Novel quasi-mesenchymal state of extravillous trophoblasts and its regulation during pregnancy.. [DOI: 10.21203/rs.3.rs-2364868/v1] [Reference Citation Analysis]
|
| 20 |
Zhang X, Wen J, Zhang G, Fan W, Tan J, Liu H, Li J. Identification and Validation of Novel Immunogenic Cell Death- and DNA Damage Response-Related Molecular Patterns Correlated with Immune Status and Prognosis in Hepatocellular Carcinoma. Transl Oncol 2022;27:101600. [PMID: 36481605 DOI: 10.1016/j.tranon.2022.101600] [Reference Citation Analysis]
|
| 21 |
Yao M, Wang JJ, Chen XY, Sai WL, Yang J, Wang DF, Wang L, Yao DF. Oncogenic Wnt3a is a promising sensitive biomarker for monitoring hepatocarcinogenesis. Hepatobiliary Pancreat Dis Int 2022:S1499-3872(22)00250-8. [PMID: 36435702 DOI: 10.1016/j.hbpd.2022.11.004] [Reference Citation Analysis]
|
| 22 |
Leung RWH, Lee TKW. Wnt/β-Catenin Signaling as a Driver of Stemness and Metabolic Reprogramming in Hepatocellular Carcinoma. Cancers 2022;14:5468. [DOI: 10.3390/cancers14215468] [Reference Citation Analysis]
|
| 23 |
Zhang J, Xun M, Li C, Chen Y. The O-GlcNAcylation and its promotion to hepatocellular carcinoma. Biochim Biophys Acta Rev Cancer 2022;1877:188806. [PMID: 36152903 DOI: 10.1016/j.bbcan.2022.188806] [Reference Citation Analysis]
|
| 24 |
Zeng F, Dai H, Li X, Guo L, Jia N, Yang J, Huang D, Zeng H, Chen W, Zhang L, Qin G. Preoperative radiomics model using gadobenate dimeglumine-enhanced magnetic resonance imaging for predicting β-catenin mutation in patients with hepatocellular carcinoma: A retrospective study. Front Oncol 2022;12:916126. [DOI: 10.3389/fonc.2022.916126] [Reference Citation Analysis]
|
| 25 |
Xing Y, Hu Y, Zou H, Xie H, Jiang T, Liu L. A novel O2- (2,4-dinitrophenyl) diazeniumdiolate inhibits hepatocellular carcinoma migration, invasion, and EMT through the Wnt/β-catenin pathway. Toxicol In Vitro 2022;84:105456. [PMID: 35985571 DOI: 10.1016/j.tiv.2022.105456] [Reference Citation Analysis]
|
| 26 |
Pouliquen DL, Boissard A, Henry C, Coqueret O, Guette C. Curcuminoids as Modulators of EMT in Invasive Cancers: A Review of Molecular Targets With the Contribution of Malignant Mesothelioma Studies. Front Pharmacol 2022;13:934534. [DOI: 10.3389/fphar.2022.934534] [Reference Citation Analysis]
|
| 27 |
Shang C, Ke M, Liu L, Wang C, Liu Y, Zheng X. Exosomes From Cancer-Associated Mesenchymal Stem Cells Transmit TMBIM6 to Promote the Malignant Behavior of Hepatocellular Carcinoma via Activating PI3K/AKT Pathway. Front Oncol 2022;12:868726. [PMID: 35720012 DOI: 10.3389/fonc.2022.868726] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 28 |
Kim NY, Mohan CD, Chinnathambi A, Alharbi SA, Sethi G, Rangappa KS, Ahn KS. Euphorbiasteroid Abrogates EGFR and Wnt/β-Catenin Signaling in Non-Small-Cell Lung Cancer Cells to Impart Anticancer Activity. Molecules 2022;27:3824. [PMID: 35744950 DOI: 10.3390/molecules27123824] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 29 |
Kim NY, Jung YY, Yang MH, Chinnathambi A, Govindasamy C, Narula AS, Namjoshi OA, Blough BE, Ahn KS. Tanshinone IIA exerts autophagic cell death through down-regulation of β-catenin in renal cell carcinoma cells. Biochimie 2022:S0300-9084(22)00150-X. [PMID: 35654241 DOI: 10.1016/j.biochi.2022.05.018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 30 |
Xu H, Li B. MicroRNA-582-3p targeting ribonucleotide reductase regulatory subunit M2 inhibits the tumorigenesis of hepatocellular carcinoma by regulating the Wnt/β-catenin signaling pathway. Bioengineered 2022;13:12876-87. [PMID: 35609318 DOI: 10.1080/21655979.2022.2078026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 31 |
Mirzaei S, Saghari S, Bassiri F, Raesi R, Zarrabi A, Hushmandi K, Sethi G, Tergaonkar V. NF-κB as a regulator of cancer metastasis and therapy response: A focus on epithelial-mesenchymal transition. J Cell Physiol 2022. [PMID: 35561232 DOI: 10.1002/jcp.30759] [Cited by in Crossref: 6] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 32 |
Mahabady MK, Mirzaei S, Saebfar H, Gholami MH, Zabolian A, Hushmandi K, Hashemi F, Tajik F, Hashemi M, Kumar AP, Aref AR, Zarrabi A, Khan H, Hamblin MR, Nuri Ertas Y, Samarghandian S. Noncoding RNAs and their therapeutics in paclitaxel chemotherapy: Mechanisms of initiation, progression, and drug sensitivity. J Cell Physiol 2022;237:2309-44. [PMID: 35437787 DOI: 10.1002/jcp.30751] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
| 33 |
Cui H, Guo D, Zhang X, Zhu Y, Wang Z, Jin Y, Guo W, Zhang S. ENO3 Inhibits Growth and Metastasis of Hepatocellular Carcinoma via Wnt/β-Catenin Signaling Pathway. Front Cell Dev Biol 2021;9:797102. [PMID: 35004693 DOI: 10.3389/fcell.2021.797102] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 34 |
Mohan CD, Yang MH, Rangappa S, Chinnathambi A, Alharbi SA, Alahmadi TA, Deivasigamani A, Hui KM, Sethi G, Rangappa KS, Ahn KS. 3-Formylchromone Counteracts STAT3 Signaling Pathway by Elevating SHP-2 Expression in Hepatocellular Carcinoma. Biology (Basel) 2021;11:29. [PMID: 35053027 DOI: 10.3390/biology11010029] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
